Chloroform

Chloroform

SCHEMBL7815652

COc1cc(C(C)=O)cc(OC)c1OC.ClC(Cl)Cl

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.60
PDK1 Q15118 1/20 0.51
TUBB4A P04350 2/20 0.50
TUBB P07437 2/20 0.50
TUBA3C P0DPH7 2/20 0.50
TUBA1B P68363 2/20 0.50
TUBA4A P68366 2/20 0.50
TUBB4B P68371 2/20 0.50
TUBB3 Q13509 2/20 0.50
TUBB2A Q13885 2/20 0.50
TUBB8 Q3ZCM7 2/20 0.50
TUBA3E Q6PEY2 2/20 0.50
TUBA1A Q71U36 2/20 0.50
TUBA1C Q9BQE3 2/20 0.50
TUBB6 Q9BUF5 2/20 0.50
TUBB2B Q9BVA1 2/20 0.50
TUBB1 Q9H4B7 2/20 0.50
MAPT P10636 3/20 0.49
ALDH1A1 P00352 2/20 0.49
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL290542 0.92 LMNA (0.69) LMNATUBB4ATUBBTUBA3CTUBA1B
Hydrochloric Acid SCHEMBL29142671 0.90 LMNA (0.67) LMNATUBB4ATUBBTUBA3CTUBA1B
Butane SCHEMBL3738130 0.85 LMNA (0.60) LMNATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1188555 0.83 ALDH1A1 (0.68) LMNATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL16502260 0.81 LMNA (0.60) LMNATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL12245712 0.81 TPMT (0.73) LMNATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL786462 0.81 LMNA (0.60) LMNATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL24861057 0.80 NCOA1 (0.55) LMNAMAPTALDH1A1POLBMAPK1
SCHEMBL1134614 0.79 TSHR (0.72) LMNAMAPTALDH1A1TPMTKMT2A
SCHEMBL7374627 0.79 LMNA (0.58) LMNATUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0574510-B1 2,4-DIARYL-1,3-DITHIOLANES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS CT FOR INNOVATIVE TECHNOLOGY (US) 2001-09-05 EP disclosed
US-5639782-A ANTIINFLAMMATORY AGENT; ANTIALLERGENS CENTER FOR INNOVATIVE TECHNOLOGY (US) 1997-06-17 US disclosed
EP-0574510-A4 NEOLIGNAN DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS INNOVATIVE TECH CENTER (US) 1994-07-06 EP disclosed
EP-0574510-A1 NEOLIGNAN DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS CENTER FOR INNOVATIVE TECHNOLOGY (US) 1993-12-22 EP disclosed
WO-1992015294-A1 NEOLIGNAN DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS CENTER FOR INNOVATIVE TECHNOLOGY (US) 1992-09-17 WO disclosed